Method of treating conditions with estrogen agonists
CA 2198562 C · Owner: Thompson, David Duane · Inventors: Thompson, David Duane; Maclean, David Burton
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pharmaceutical compositions that comprise compounds of this formula, (see fig. I), (wherein A is CH2 or NR; R is H or alkyl; B D and E are each, CH or N; Y is a cyclic group such as phenyl; Z1 is a divalent group such as -O-CH2CH2-; G is an optionally substituted amino such as piperidino or pyrrolidino; and e is 0 1 or 2) are, useful for treating or preventing Alzheimer's disease premenstrual syndrome, perimenopausal syndrome a deficiency of, thrombomodulin, uterine fibrosis excessive myeloproxidase, activity, excessive thrombin autoimmune disease, reperfusion, damage of ischemic myocardium and insufficient testosterone.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 26, 1997 and granted September 10, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 26, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 26, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.